Clients / Services

M2Gen is committed to delivering to our clients great service and great science. M2Gen is uniquely positioned to partner with the biopharmaceutical industry to chart the future of personalized drug development and move quickly toward the goal of more highly-effective treatment for individuals stricken with cancer. Our strengths and capabilities include deep knowledge of the biopharmaceutical industry’s needs and partnering capabilities; leadership experience in the healthcare service market and world-class oncology, scientific and clinical expertise. M2Gen is unmatched worldwide in its ability to develop consortia and provide the training, infrastructure and logistics for the acquisition and analysis of high-quality tumors and longitudinal clinical data.

We serve biopharmaceutical research and development and clinical research organizations in the following ways:

Discovery & Validation - providing the highest quality, well-annotated tissue samples needed for discovery and validation purposes;

Biomarker Development - expediting biomarker development in the diagnostic space via unlimited access to the world’s largest cancer-focused biorepository linked to longitudinal clinical data and molecular data to speed validation and commercialization;

Personalized Medicine Development Services Organization (PMDSO) - optimizing patient outcomes in oncology by matching the right patient to the right clinical trial with our Personalized Medicine Development Services Organization  (This business line should be operational in 2011.);

Biorepository - offering drug development organizations access to samples collected from a high volume of active and involved patients connected via an expanding consortium network of hospitals and large cancer clinics nationwide (By 2011, we expect to expand the Consortium Network internationally.);

Biointelligence and Data Warehouse - providing comprehensive research services in Biointelligence that includes scalable data capture, data quality review and automation, clinical outcomes analysis, data mining, biostatistics, predictive modeling, artificial intelligence, and more.